IGF-1 activates phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/ mammalian target of rapamycin 1 (mTORC1) signaling pathways in cancerous cells to promote glycolysis and tumor cell proliferation, while simultaneously inhibiting apoptosis (17–20). The gene discussed is IGF1; the disease is neoplasm.